Donnem et al.31 have reported that stromal CD8+ T-cell density is an independent prognostic factor for OS, and its prognostic effect increases in different stages in patients with stage I-IIIA NSCLC. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.